glp-1 weight loss drugs competitive analysis Market Size to Hit USD 132.79 Bn by 2035 Novo Nordisk vs Eli Lilly:
Description
doi: 10.1007/s13300-020-00786-1
15 percent still said they spent too much time thinking about food (a 48 percent drop) and 20 percent claimed their diet had a negative effect on their lives (a 40 percent drop)
[cited 2025 Nov 20]
Their drug of choice is hunger. Calm the noise and the craving for that reward triggerwith careful monitoring from a health care professionaland patients may be better able to heal
